Alliance for Clinical Trials in Oncology: all 509 studies

Page 5 of 6. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.

• Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung CancerCompletedNCT00006349Phase 3
• Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentCompletedNCT00006348Phase 3
• Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00006265Phase 2
• Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the ProstateCompletedNCT00006214Phase 2
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaCompletedNCT00006125Phase 2
• Combination Chemotherapy in Treating Patients With Colorectal CancerCompletedNCT00006103Phase 3
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00006029Phase 1/2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00006012Phase 1/2
• Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver CancerCompletedNCT00006010Phase 2
• LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNCT00006007Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung CancerCompletedNCT00005972Phase 2
• Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00005964Phase 2
• Docetaxel and Carboplatin in Treating Women With Metastatic Breast CancerCompletedNCT00005963Phase 2
• Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00005850Phase 2
• Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic LeukemiaCompletedNCT00005829Phase 2
• Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005828Phase 2
• Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005820Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005810Phase 2
• Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00005646Phase 2
• Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the LungCompletedNCT00005610Phase 2
• Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00005601Phase 2
• Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung CancerCompletedNCT00005059Phase 2
• Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon AlfaTerminatedNCT00004933Phase 3
• Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast CancerCompletedNCT00004893Phase 2
• Positron Emission Tomography in Determining Stage of Esophageal CancerCompletedNCT00004867Not applicable
• Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00004857Phase 2
• 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentTerminatedNCT00004239Phase 1
• Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or StomachCompletedNCT00004235Phase 2
• Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00004190Phase 2
• Capecitabine in Treating Patients With Malignant MesotheliomaCompletedNCT00004183Phase 2
• Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00004139Phase 2
• Positron Emission Tomography for Detecting Non-small Cell Lung CancerCompletedNCT00004138Not applicable
• Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004055Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00003996Phase 2
• Diagnostic Study of Gene Alterations in Patients With Acute Myeloid LeukemiaCompletedNCT00003931
• Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerCompletedNCT00003900Phase 2
• Diagnostic Study of Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00003863
• Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic LeukemiaActive, not recruitingNCT00003861
• Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for RecurrenceWithdrawnNCT00003858Phase 2
• Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast CancerCompletedNCT00003855Phase 3
• Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast CancerCompletedNCT00003854Phase 3
• Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00003849Phase 2
• Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00003834Phase 2
• Genetic Study in Patients With Stage II or Stage III Colon CancerCompletedNCT00003833
• Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung CancerCompletedNCT00003831Phase 3
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00003829Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00003812Phase 2
• Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00003762Phase 2
• Conventional or Video-Assisted Surgery in Treating Patients With Lung MetastasesCompletedNCT00003724Phase 3
• Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerCompletedNCT00003704Phase 1
• Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00003700Phase 2
• Video-Assisted Surgery in Treating Patients With Non-small Cell Lung CancerCompletedNCT00003692Phase 2
• Topotecan in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003675Phase 2
• Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate CancerCompletedNCT00003674Phase 3
• Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung CancerCompletedNCT00003666Phase 2
• Genetic Study of Patients and Families With a History of Colorectal CancerCompletedNCT00003648
• High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder CancerCompletedNCT00003623Phase 3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic AstrocytomaCompletedNCT00003621Phase 2
• Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00003612Phase 2
• Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ TransplantationCompletedNCT00003611Not applicable
• Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation TherapyCompletedNCT00003610Phase 3
• Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyCompletedNCT00003600Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00003594Phase 3
• Gene Testing in Patients With Colon CancerCompletedNCT00003571
• Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung CancerCompletedNCT00003566Not applicable
• Docetaxel in Treating Patients With Solid TumorsCompletedNCT00003565Phase 2
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00003546Phase 2
• Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryCompletedNCT00003387Phase 3
• Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]TerminatedNCT00003381
• Irinotecan in Treating Patients With Refractory Metastatic Breast CancerCompletedNCT00003351Phase 2
• Hormone Therapy in Treating Patients With Prostate CancerCompletedNCT00003323Phase 2
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung CancerCompletedNCT00003317Phase 3
• Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00003299Phase 3
• Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung CancerCompletedNCT00003281Phase 2
• Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's LymphomaCompletedNCT00003278Phase 2
• Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct CancerCompletedNCT00003276Phase 2
• Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous LeukemiaCompletedNCT00003255Phase 2
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic LeukemiaCompletedNCT00003248Phase 2
• Glutamine in Preventing Acute Diarrhea in Patients With Pelvic CancerCompletedNCT00003170Phase 3
• Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or StomachCompletedNCT00003157Phase 1
• Irinotecan in Treating Patients With Advanced Cancer of the StomachCompletedNCT00003137Phase 2
• Irinotecan in Treating Patients With Recurrent GliomaCompletedNCT00003134Phase 2
• Paclitaxel in Treating Women With Recurrent Solid TumorsCompletedNCT00003130Phase 2
• Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusCompletedNCT00003118Phase 3
• Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00003117Phase 3
• Paclitaxel in Treating Older Patients With Solid TumorsCompletedNCT00003092Phase 3
• Combination Chemotherapy in Treating Patients With Breast CancerCompletedNCT00003088Phase 3
• Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight LossCompletedNCT00003077Phase 1/2
• Detection of Early Metastases in Patients With Stage I Non-small Cell Lung CancerCompletedNCT00003006
• Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast CancerCompletedNCT00002998Phase 2
• Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid TumorsCompletedNCT00002994Phase 1
• Surgery in Treating Patients With Prostate CancerCompletedNCT00002938Phase 2
• Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone TherapyCompletedNCT00002924
• Radiation Therapy With Androgen Suppression in Treating Patients With Prostate CancerCompletedNCT00002889Phase 2
• Etoposide in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00002880Phase 2
• Cladribine in Patients With Mantle Cell LymphomaCompletedNCT00002879Phase 2
• Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial GliomaCompletedNCT00002806Phase 2
• Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's LymphomaCompletedNCT00002779Phase 2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second RemissionCompletedNCT00002768Phase 2
• Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast CancerCompletedNCT00002762

← Alliance for Clinical Trials in Oncology overview and focus areas